BioCentury
ARTICLE | Company News

Cel-Sci and NCI collaborate

June 15, 2000 7:00 AM UTC

Cel-Sci (CVM; Berlin:LSR) entered into a CRADA with the NCI to develop vaccines to treat or prevent HIV using NCI's HIV peptide epitopes and CVM's Ligand Epitope Antigen Presentation System ( L.E.A.P....